LYONDELLBASELL INDU-CL A (LYB) Fundamental Analysis & Valuation

NYSE:LYB • NL0009434992

Current stock price

78.345 USD
+1.16 (+1.5%)
Last:

This LYB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. LYB Profitability Analysis

1.1 Basic Checks

  • In the past year LYB was profitable.
  • In the past year LYB had a positive cash flow from operations.
  • LYB had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years LYB had a positive operating cash flow.
LYB Yearly Net Income VS EBIT VS OCF VS FCFLYB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

1.2 Ratios

  • LYB's Return On Assets of -2.21% is in line compared to the rest of the industry. LYB outperforms 40.96% of its industry peers.
  • The Return On Equity of LYB (-7.46%) is worse than 61.45% of its industry peers.
  • The Return On Invested Capital of LYB (2.51%) is worse than 60.24% of its industry peers.
  • LYB had an Average Return On Invested Capital over the past 3 years of 6.66%. This is in line with the industry average of 6.51%.
  • The last Return On Invested Capital (2.51%) for LYB is well below the 3 year average (6.66%), which needs to be investigated, but indicates that LYB had better years and this may not be a problem.
Industry RankSector Rank
ROA -2.21%
ROE -7.46%
ROIC 2.51%
ROA(3y)2.42%
ROA(5y)6.64%
ROE(3y)6.57%
ROE(5y)19.56%
ROIC(3y)6.66%
ROIC(5y)11.12%
LYB Yearly ROA, ROE, ROICLYB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

  • With a Operating Margin value of 2.76%, LYB is not doing good in the industry: 62.65% of the companies in the same industry are doing better.
  • LYB's Operating Margin has declined in the last couple of years.
  • The Gross Margin of LYB (8.55%) is worse than 83.13% of its industry peers.
  • LYB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.76%
PM (TTM) N/A
GM 8.55%
OM growth 3Y-35.45%
OM growth 5Y-18.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.25%
GM growth 5Y-6.92%
LYB Yearly Profit, Operating, Gross MarginsLYB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

3

2. LYB Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LYB is destroying value.
  • Compared to 1 year ago, LYB has less shares outstanding
  • LYB has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for LYB is higher compared to a year ago.
LYB Yearly Shares OutstandingLYB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
LYB Yearly Total Debt VS Total AssetsLYB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • LYB has an Altman-Z score of 2.04. This is not the best score and indicates that LYB is in the grey zone with still only limited risk for bankruptcy at the moment.
  • LYB has a Altman-Z score (2.04) which is in line with its industry peers.
  • The Debt to FCF ratio of LYB is 33.69, which is on the high side as it means it would take LYB, 33.69 years of fcf income to pay off all of its debts.
  • LYB's Debt to FCF ratio of 33.69 is in line compared to the rest of the industry. LYB outperforms 43.37% of its industry peers.
  • LYB has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.22, LYB is not doing good in the industry: 71.08% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 33.69
Altman-Z 2.04
ROIC/WACC0.33
WACC7.63%
LYB Yearly LT Debt VS Equity VS FCFLYB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • LYB has a Current Ratio of 1.77. This is a normal value and indicates that LYB is financially healthy and should not expect problems in meeting its short term obligations.
  • LYB's Current ratio of 1.77 is in line compared to the rest of the industry. LYB outperforms 45.78% of its industry peers.
  • A Quick Ratio of 1.20 indicates that LYB should not have too much problems paying its short term obligations.
  • LYB has a Quick ratio of 1.20. This is comparable to the rest of the industry: LYB outperforms 45.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.2
LYB Yearly Current Assets VS Current LiabilitesLYB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

3

3. LYB Growth Analysis

3.1 Past

  • LYB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.44%.
  • Measured over the past years, LYB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.44% on average per year.
  • Looking at the last year, LYB shows a very negative growth in Revenue. The Revenue has decreased by -25.18% in the last year.
  • The Revenue has been growing slightly by 1.67% on average over the past years.
EPS 1Y (TTM)-73.44%
EPS 3Y-48.49%
EPS 5Y-21.44%
EPS Q2Q%-134.67%
Revenue 1Y (TTM)-25.18%
Revenue growth 3Y-15.77%
Revenue growth 5Y1.67%
Sales Q2Q%-25.33%

3.2 Future

  • Based on estimates for the next years, LYB will show a very strong growth in Earnings Per Share. The EPS will grow by 36.17% on average per year.
  • The Revenue is expected to grow by 1.26% on average over the next years.
EPS Next Y45.49%
EPS Next 2Y49.76%
EPS Next 3Y44.39%
EPS Next 5Y36.17%
Revenue Next Year0.36%
Revenue Next 2Y0.64%
Revenue Next 3Y0.9%
Revenue Next 5Y1.26%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LYB Yearly Revenue VS EstimatesLYB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B 50B
LYB Yearly EPS VS EstimatesLYB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

2

4. LYB Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 46.09, the valuation of LYB can be described as expensive.
  • Based on the Price/Earnings ratio, LYB is valued a bit more expensive than 62.65% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.61, LYB is valued quite expensively.
  • With a Price/Forward Earnings ratio of 31.68, LYB can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LYB is on the same level as its industry peers.
  • LYB is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 46.09
Fwd PE 31.68
LYB Price Earnings VS Forward Price EarningsLYB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as LYB.
  • LYB's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 65.73
EV/EBITDA 15.37
LYB Per share dataLYB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • LYB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • LYB's earnings are expected to grow with 44.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.01
PEG (5Y)N/A
EPS Next 2Y49.76%
EPS Next 3Y44.39%

5

5. LYB Dividend Analysis

5.1 Amount

  • LYB has a Yearly Dividend Yield of 3.70%. Purely for dividend investing, there may be better candidates out there.
  • LYB's Dividend Yield is rather good when compared to the industry average which is at 2.12. LYB pays more dividend than 86.75% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, LYB pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.7%

5.2 History

  • The dividend of LYB has a limited annual growth rate of 5.33%.
  • LYB has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of LYB decreased recently.
Dividend Growth(5Y)5.33%
Div Incr Years1
Div Non Decr Years1
LYB Yearly Dividends per shareLYB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

5.3 Sustainability

  • The earnings of LYB are negative and hence is the payout ratio. LYB will probably not be able to sustain this dividend level.
  • LYB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-234.57%
EPS Next 2Y49.76%
EPS Next 3Y44.39%
LYB Yearly Income VS Free CF VS DividendLYB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

LYB Fundamentals: All Metrics, Ratios and Statistics

LYONDELLBASELL INDU-CL A

NYSE:LYB (3/26/2026, 11:44:05 AM)

78.345

+1.16 (+1.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-30
Earnings (Next)04-23
Inst Owners74.34%
Inst Owner Change2.63%
Ins Owners0.18%
Ins Owner Change0.52%
Market Cap25.24B
Revenue(TTM)30.15B
Net Income(TTM)-752.00M
Analysts52.14
Price Target52.2 (-33.37%)
Short Float %8.53%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield 3.7%
Yearly Dividend5.46
Dividend Growth(5Y)5.33%
DP-234.57%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-137.75%
Min EPS beat(2)-299.66%
Max EPS beat(2)24.17%
EPS beat(4)1
Avg EPS beat(4)-80.58%
Min EPS beat(4)-299.66%
Max EPS beat(4)24.17%
EPS beat(8)3
Avg EPS beat(8)-39.32%
EPS beat(12)7
Avg EPS beat(12)-20.1%
EPS beat(16)10
Avg EPS beat(16)-15.37%
Revenue beat(2)2
Avg Revenue beat(2)3.27%
Min Revenue beat(2)3.26%
Max Revenue beat(2)3.27%
Revenue beat(4)4
Avg Revenue beat(4)2.27%
Min Revenue beat(4)0.76%
Max Revenue beat(4)3.27%
Revenue beat(8)7
Avg Revenue beat(8)1.06%
Revenue beat(12)8
Avg Revenue beat(12)0.1%
Revenue beat(16)10
Avg Revenue beat(16)0.24%
PT rev (1m)0.22%
PT rev (3m)-4.59%
EPS NQ rev (1m)10.82%
EPS NQ rev (3m)-69.55%
EPS NY rev (1m)-8.43%
EPS NY rev (3m)-31.28%
Revenue NQ rev (1m)1.05%
Revenue NQ rev (3m)0.49%
Revenue NY rev (1m)1.73%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 46.09
Fwd PE 31.68
P/S 0.84
P/FCF 65.73
P/OCF 11.16
P/B 2.5
P/tB 2.83
EV/EBITDA 15.37
EPS(TTM)1.7
EY2.17%
EPS(NY)2.47
Fwd EY3.16%
FCF(TTM)1.19
FCFY1.52%
OCF(TTM)7.02
OCFY8.96%
SpS93.59
BVpS31.29
TBVpS27.7
PEG (NY)1.01
PEG (5Y)N/A
Graham Number34.6
Profitability
Industry RankSector Rank
ROA -2.21%
ROE -7.46%
ROCE 2.98%
ROIC 2.51%
ROICexc 2.86%
ROICexgc 3%
OM 2.76%
PM (TTM) N/A
GM 8.55%
FCFM 1.27%
ROA(3y)2.42%
ROA(5y)6.64%
ROE(3y)6.57%
ROE(5y)19.56%
ROIC(3y)6.66%
ROIC(5y)11.12%
ROICexc(3y)7.53%
ROICexc(5y)12.09%
ROICexgc(3y)8.19%
ROICexgc(5y)13.23%
ROCE(3y)7.89%
ROCE(5y)13.24%
ROICexgc growth 3Y-44.26%
ROICexgc growth 5Y-15.95%
ROICexc growth 3Y-43.41%
ROICexc growth 5Y-15.05%
OM growth 3Y-35.45%
OM growth 5Y-18.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.25%
GM growth 5Y-6.92%
F-Score3
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 33.69
Debt/EBITDA 5.56
Cap/Depr 135.11%
Cap/Sales 6.23%
Interest Coverage 1.72
Cash Conversion 101.85%
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.2
Altman-Z 2.04
F-Score3
WACC7.63%
ROIC/WACC0.33
Cap/Depr(3y)118.58%
Cap/Depr(5y)129.11%
Cap/Sales(3y)5.44%
Cap/Sales(5y)4.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.44%
EPS 3Y-48.49%
EPS 5Y-21.44%
EPS Q2Q%-134.67%
EPS Next Y45.49%
EPS Next 2Y49.76%
EPS Next 3Y44.39%
EPS Next 5Y36.17%
Revenue 1Y (TTM)-25.18%
Revenue growth 3Y-15.77%
Revenue growth 5Y1.67%
Sales Q2Q%-25.33%
Revenue Next Year0.36%
Revenue Next 2Y0.64%
Revenue Next 3Y0.9%
Revenue Next 5Y1.26%
EBIT growth 1Y-69.96%
EBIT growth 3Y-45.63%
EBIT growth 5Y-17.24%
EBIT Next Year120.66%
EBIT Next 3Y44.31%
EBIT Next 5Y31.66%
FCF growth 1Y-80.61%
FCF growth 3Y-55.05%
FCF growth 5Y-23.41%
OCF growth 1Y-40.77%
OCF growth 3Y-28.23%
OCF growth 5Y-7.85%

LYONDELLBASELL INDU-CL A / LYB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for LYONDELLBASELL INDU-CL A?

ChartMill assigns a fundamental rating of 3 / 10 to LYB.


What is the valuation status of LYONDELLBASELL INDU-CL A (LYB) stock?

ChartMill assigns a valuation rating of 2 / 10 to LYONDELLBASELL INDU-CL A (LYB). This can be considered as Overvalued.


How profitable is LYONDELLBASELL INDU-CL A (LYB) stock?

LYONDELLBASELL INDU-CL A (LYB) has a profitability rating of 3 / 10.


How financially healthy is LYONDELLBASELL INDU-CL A?

The financial health rating of LYONDELLBASELL INDU-CL A (LYB) is 3 / 10.


What is the earnings growth outlook for LYONDELLBASELL INDU-CL A?

The Earnings per Share (EPS) of LYONDELLBASELL INDU-CL A (LYB) is expected to grow by 45.49% in the next year.